Morningside Group For Profit

The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.

Founded Date: 1986-01-01
Investor Type: University Program
Employee Number: 51-100
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Number Of Exists: 32
Technology: Other type
Investors Number: 154
Industry: Omics-Based Biomarkers
Headquarters: Newton Center, Massachusetts, United States
Estimated Revenue: $4.9Mper year